DE4112440C1 - - Google Patents

Info

Publication number
DE4112440C1
DE4112440C1 DE4112440A DE4112440A DE4112440C1 DE 4112440 C1 DE4112440 C1 DE 4112440C1 DE 4112440 A DE4112440 A DE 4112440A DE 4112440 A DE4112440 A DE 4112440A DE 4112440 C1 DE4112440 C1 DE 4112440C1
Authority
DE
Germany
Prior art keywords
selection
nucleic acid
mutagenesis
cycle
acid sequences
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE4112440A
Other languages
German (de)
English (en)
Inventor
Karsten Dr. 4006 Erkrath De Henco
Manfred Prof. Dr. 3400 Goettingen De Eigen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Diagen Institut fur Molekularbiologische Diagnostik 4000 Duesseldorf De GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6429722&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE4112440(C1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Diagen Institut fur Molekularbiologische Diagnostik 4000 Duesseldorf De GmbH filed Critical Diagen Institut fur Molekularbiologische Diagnostik 4000 Duesseldorf De GmbH
Priority to DE4112440A priority Critical patent/DE4112440C1/de
Priority to DE59209506T priority patent/DE59209506D1/de
Priority to AT92908537T priority patent/ATE171479T1/de
Priority to PCT/EP1992/000840 priority patent/WO1992018645A1/de
Priority to EP92908537A priority patent/EP0583265B1/de
Priority to JP50798892A priority patent/JP3504658B2/ja
Publication of DE4112440C1 publication Critical patent/DE4112440C1/de
Application granted granted Critical
Priority to US08/507,190 priority patent/US5795747A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1058—Directional evolution of libraries, e.g. evolution of libraries is achieved by mutagenesis and screening or selection of mixed population of organisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1079—Screening libraries by altering the phenotype or phenotypic trait of the host

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Ecology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
DE4112440A 1991-04-16 1991-04-16 Expired - Lifetime DE4112440C1 (enExample)

Priority Applications (7)

Application Number Priority Date Filing Date Title
DE4112440A DE4112440C1 (enExample) 1991-04-16 1991-04-16
EP92908537A EP0583265B1 (de) 1991-04-16 1992-04-14 Verfahren zur herstellung von neuen biopolymeren
AT92908537T ATE171479T1 (de) 1991-04-16 1992-04-14 Verfahren zur herstellung von neuen biopolymeren
PCT/EP1992/000840 WO1992018645A1 (de) 1991-04-16 1992-04-14 Verfahren zur herstellung von neuen biopolymeren
DE59209506T DE59209506D1 (de) 1991-04-16 1992-04-14 Verfahren zur herstellung von neuen biopolymeren
JP50798892A JP3504658B2 (ja) 1991-04-16 1992-04-14 新規生体高分子の製造方法
US08/507,190 US5795747A (en) 1991-04-16 1995-06-26 Process for manufacturing new biopolymers

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4112440A DE4112440C1 (enExample) 1991-04-16 1991-04-16

Publications (1)

Publication Number Publication Date
DE4112440C1 true DE4112440C1 (enExample) 1992-10-22

Family

ID=6429722

Family Applications (2)

Application Number Title Priority Date Filing Date
DE4112440A Expired - Lifetime DE4112440C1 (enExample) 1991-04-16 1991-04-16
DE59209506T Expired - Lifetime DE59209506D1 (de) 1991-04-16 1992-04-14 Verfahren zur herstellung von neuen biopolymeren

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE59209506T Expired - Lifetime DE59209506D1 (de) 1991-04-16 1992-04-14 Verfahren zur herstellung von neuen biopolymeren

Country Status (5)

Country Link
EP (1) EP0583265B1 (enExample)
JP (1) JP3504658B2 (enExample)
AT (1) ATE171479T1 (enExample)
DE (2) DE4112440C1 (enExample)
WO (1) WO1992018645A1 (enExample)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994010572A1 (de) * 1992-11-05 1994-05-11 Evotec Biosystems Gmbh Trägermaterial zur simultanen bindung genotypischer und phänotypischer substanzen
US7235386B2 (en) 2001-02-02 2007-06-26 Large Scale Biology Corporation Method of increasing complementarity in a heteroduplex
US7273739B2 (en) 2002-02-01 2007-09-25 Padgett Hal S Nucleic acid molecules encoding endonucleases and methods of use thereof
US7582423B2 (en) 2001-02-02 2009-09-01 Novici Biotech Llc Population of polynucleotide sequence variants
US7838219B2 (en) 2001-02-02 2010-11-23 Novici Biotech Llc Method of increasing complementarity in a heteroduplex

Families Citing this family (82)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5849545A (en) * 1992-05-11 1998-12-15 Evotec Biosystems Gmbh Substrate material for simultaneously binding genotypic and phenotypic substances
DE4343591A1 (de) * 1993-12-21 1995-06-22 Evotec Biosystems Gmbh Verfahren zum evolutiven Design und Synthese funktionaler Polymere auf der Basis von Formenelementen und Formencodes
US6309883B1 (en) 1994-02-17 2001-10-30 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US6165793A (en) * 1996-03-25 2000-12-26 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US6117679A (en) 1994-02-17 2000-09-12 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US5837458A (en) 1994-02-17 1998-11-17 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US6995017B1 (en) 1994-02-17 2006-02-07 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US6335160B1 (en) 1995-02-17 2002-01-01 Maxygen, Inc. Methods and compositions for polypeptide engineering
US5605793A (en) 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
EP0714980A1 (en) * 1994-12-02 1996-06-05 Institut Pasteur Hypermutagenesis
WO1996017056A1 (en) * 1994-12-02 1996-06-06 Institut Pasteur Hypermutagenesis
US6936289B2 (en) 1995-06-07 2005-08-30 Danisco A/S Method of improving the properties of a flour dough, a flour dough improving composition and improved food products
JPH1066577A (ja) * 1996-08-07 1998-03-10 Novo Nordisk As 核酸プールおよびその製造方法
US8207093B2 (en) 1997-01-21 2012-06-26 The General Hospital Corporation Selection of proteins using RNA-protein fusions
US6261804B1 (en) 1997-01-21 2001-07-17 The General Hospital Corporation Selection of proteins using RNA-protein fusions
DK0971946T3 (da) 1997-01-21 2006-10-30 Gen Hospital Corp Selektion af proteiner ved anvendelse af RNA-protein-fusioner
US6153410A (en) * 1997-03-25 2000-11-28 California Institute Of Technology Recombination of polynucleotide sequences using random or defined primers
EP1433852B1 (en) 1997-04-09 2006-06-28 Danisco A/S Use of lipase for improving doughs and baked products
AU754377B2 (en) * 1997-09-03 2002-11-14 Merck Patent Gesellschaft Mit Beschrankter Haftung Methods for protein screening
US6927025B1 (en) 1997-09-03 2005-08-09 Biovation Limited Methods for protein screening
ATE311443T1 (de) * 1997-09-03 2005-12-15 Biovation Ltd Methoden zur durchforstung (screenen) von proteinen
AU746786B2 (en) 1997-12-08 2002-05-02 California Institute Of Technology Method for creating polynucleotide and polypeptide sequences
US7153655B2 (en) 1998-06-16 2006-12-26 Alligator Bioscience Ab Method for in vitro molecular evolution of protein function involving the use of exonuclease enzyme and two populations of parent polynucleotide sequence
US6337186B1 (en) 1998-06-17 2002-01-08 Maxygen, Inc. Method for producing polynucleotides with desired properties
US6846655B1 (en) 1998-06-29 2005-01-25 Phylos, Inc. Methods for generating highly diverse libraries
DK1098988T4 (da) 1998-07-21 2007-09-03 Danisco Födevare
ES2329205T3 (es) 1998-08-17 2009-11-23 Bristol-Myers Squibb Company Identificacion de interacciones de compuestos-proteinas usando bibliotecas de moleculas de fusion de proteinas-acidos nucleicos.
DE19953854C2 (de) 1999-11-09 2002-01-17 Max Planck Gesellschaft Verfahren zur Herstellung von Biopolymeren mit veränderten Eigenschaften
AU783689B2 (en) 2000-01-24 2005-11-24 Adnexus Therapeutics, Inc. Sensitive, multiplexed diagnostic assays for protein analysis
US7022479B2 (en) 2000-01-24 2006-04-04 Compound Therapeutics, Inc. Sensitive, multiplexed diagnostic assays for protein analysis
US6958213B2 (en) 2000-12-12 2005-10-25 Alligator Bioscience Ab Method for in vitro molecular evolution of protein function
US20020086292A1 (en) 2000-12-22 2002-07-04 Shigeaki Harayama Synthesis of hybrid polynucleotide molecules using single-stranded polynucleotide molecules
NZ528260A (en) 2001-05-18 2005-09-30 Danisco Method of improving dough and bread quality with the addition of an enzyme that hydrolyses a glycolipid and a phospholipid and incapable of hydrolysing a triglyceride or monoglyceride
EP1840211A1 (en) 2001-10-31 2007-10-03 Danisco A/S Pyranosone dehydratase from phanerochaete chrysosporium
CA2485506C (en) 2002-05-17 2012-02-28 Alligator Bioscience Ab A method for in vitro molecular evolution of protein function
AU2003254356B2 (en) * 2002-07-17 2006-06-08 Unilever Plc Skin care cosmetic compositions containing carboxyalkylates of branched alcohols and/or alkoxylates thereof
US20050196766A1 (en) 2003-12-24 2005-09-08 Soe Jorn B. Proteins
MXPA05007654A (es) 2003-01-17 2005-09-30 Danisco Metodo.
US7955814B2 (en) 2003-01-17 2011-06-07 Danisco A/S Method
EP3323887A3 (en) 2003-01-17 2018-09-12 DuPont Nutrition Biosciences ApS Method for the in situ production of an emulsifier in a foodstuff
EP1633865B1 (en) 2003-06-18 2011-09-28 Bayer Pharma Aktiengesellschaft New biological entities and the use thereof
KR101169265B1 (ko) 2003-12-24 2012-08-02 대니스코 에이/에스 단백질
US7718408B2 (en) 2003-12-24 2010-05-18 Danisco A/S Method
GB0716126D0 (en) 2007-08-17 2007-09-26 Danisco Process
GB0405637D0 (en) 2004-03-12 2004-04-21 Danisco Protein
EA014985B1 (ru) 2004-07-16 2011-04-29 Даниско А/С Способ ферментативного рафинирования пищевых масел гидратацией и применение липидацилтрансферазы для осуществления способа
GB0421598D0 (en) 2004-09-29 2004-10-27 Cambridge Advanced Tech Modification of plant development and morphology
GB0422052D0 (en) 2004-10-04 2004-11-03 Dansico As Enzymes
GB0423139D0 (en) 2004-10-18 2004-11-17 Danisco Enzymes
EP2092060B1 (en) 2006-12-14 2014-01-22 DSM IP Assets B.V. R-hnl random variants and their use for preparing optically pure, sterically hindered cyanohydrins
AU2007344910B2 (en) 2007-01-25 2013-03-28 Dupont Nutrition Biosciences Aps Production of a lipid acyltransferase from transformed Bacillus licheniformis cells
US8143046B2 (en) 2007-02-07 2012-03-27 Danisco Us Inc., Genencor Division Variant Buttiauxella sp. phytases having altered properties
US20080220498A1 (en) 2007-03-06 2008-09-11 Cervin Marguerite A Variant Buttiauxella sp. phytases having altered properties
DK2147104T3 (en) 2007-05-21 2015-12-14 Danisco Us Inc USING A ASPARAGINPROTEASE- (NSP24) SIGNAL SEQUENCE FOR heterologous protein EXPRESSION
WO2009129489A2 (en) 2008-04-18 2009-10-22 Danisco Us Inc., Genencor Division Buttiauxella sp. phytase variants
EP2281034B1 (en) 2008-04-30 2015-10-21 DuPont Nutrition Biosciences ApS Process using Pseudoglucanobacter saccharoketogenes alcohol dehydrogenase
GB0908770D0 (en) 2009-04-24 2009-07-01 Danisco Method
WO2010134035A1 (en) 2009-05-19 2010-11-25 Danisco A/S Use
AR077042A1 (es) 2009-06-12 2011-07-27 Danisco Metodo para tratar una composicion que contiene pirofiofitina
GB0920089D0 (en) 2009-11-17 2009-12-30 Danisco Method
BR112012017292B1 (pt) 2010-01-13 2021-05-18 Basf Se variante de mananase, molécula de ácido nucleico, método para a preparação da mananase modificada, composição e uso da mananase modificada
WO2011110967A1 (en) 2010-03-12 2011-09-15 Danisco A/S Process
WO2011114251A1 (en) 2010-03-18 2011-09-22 Danisco A/S Foodstuff
BR112012032176A2 (pt) 2010-06-17 2015-09-08 Dupont Nutrition Biosci Aps processo de tratamento de sementes que contém óleo, método de obtenção de óleo de sementes vegetais, processo de produção de um óleo vegetal refinado e óleo vegetal bruto ou refinado que pode ser obtido por meio de um método ou processo
GB201011513D0 (en) 2010-07-08 2010-08-25 Danisco Method
CA2825628A1 (en) 2011-02-23 2012-08-30 Dupont Nutrition Biosciences Aps Method
ES2649912T3 (es) 2011-02-23 2018-01-16 Dupont Nutrition Biosciences Aps Tratamiento enzimático de la clorofila en los aceites vegetales
WO2012114232A1 (en) 2011-02-23 2012-08-30 Dupont Nutrition Biosciences Aps Process
US20140031272A1 (en) 2011-04-08 2014-01-30 Danisco Us Inc. Compositions
SMT201800284T1 (it) 2011-06-10 2018-07-17 Univ Oregon Health & Science Glicoproteine cmv e vettori ricombinanti
WO2013104659A2 (en) 2012-01-13 2013-07-18 Dupont Nutrition Biosciences Aps Process
WO2013104660A1 (en) 2012-01-13 2013-07-18 Dupont Nutrition Biosciences Aps Process for treating a plant oil comprising hydrolysing chlorophyll or a chlorophyll derivative and involving partial caustic neutralisation
WO2013160374A1 (en) 2012-04-27 2013-10-31 Dupont Nutrition Biosciences Aps Process for refining crude plant oil involving enzymatic hydrolysis and gum recycling
WO2013160372A1 (en) 2012-04-27 2013-10-31 Dupont Nutrition Biosciences Aps Process for treating plant oil involving addition of serial doses of chlorophyll or chlorophyll derivative degrading enzyme
EP2909230B1 (en) 2012-10-19 2019-05-22 Danisco US Inc. Stabilization of biomimetic membranes
CA2934039A1 (en) 2013-12-19 2015-06-25 Danisco Us Inc. Use of hydrophobins to increase gas transferin aerobic fermentation processes
WO2015150372A1 (en) 2014-04-01 2015-10-08 Dupont Nutrition Biosciences Aps Method for increasing crude palm oil yields
AU2015334890B2 (en) 2014-10-24 2021-12-23 Dupont Nutrition Biosciences Aps Proline tolerant tripeptidyl peptidases and uses thereof
US20170306360A1 (en) 2014-10-24 2017-10-26 Danisco Us Inc. Method for producing alcohol by use of a tripeptidyl peptidase
CA2990822A1 (en) 2015-06-26 2016-12-29 Dupont Nutrition Biosciences Aps Aminopeptidases for protein hydrlyzates
CA3013383A1 (en) 2016-02-25 2017-08-31 Dupont Nutrition Biosciences Aps Method for producing a protein hydrolysate employing an aspergillus fumigatus tripeptidyl peptidase
DE102023001827A1 (de) 2023-04-19 2024-10-24 Horst Wochnowski Verfahren und dazugehörige Vorrichtung zum Züchten von in Gewässern Mikroplastik zersetzenden und abbauenden Mikroorganismenstämme durch einen künstlich herbeigeführten und beschleunigten Evolutions- und Selektionsprozess

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0285123A3 (en) * 1987-04-03 1989-02-01 Stabra AG A method for complete mutagenesis of nucleic acids
ES2118066T3 (es) * 1989-10-05 1998-09-16 Optein Inc Sintesis y aislamiento, exentos de celulas, de nuevos genes y polipeptidos.
WO1992002536A1 (en) * 1990-08-02 1992-02-20 The Regents Of The University Of Colorado Systematic polypeptide evolution by reverse translation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NICHTS ERMITTELT *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994010572A1 (de) * 1992-11-05 1994-05-11 Evotec Biosystems Gmbh Trägermaterial zur simultanen bindung genotypischer und phänotypischer substanzen
US7235386B2 (en) 2001-02-02 2007-06-26 Large Scale Biology Corporation Method of increasing complementarity in a heteroduplex
US7582423B2 (en) 2001-02-02 2009-09-01 Novici Biotech Llc Population of polynucleotide sequence variants
US7833759B2 (en) 2001-02-02 2010-11-16 Novici Biotech Llc Method of increasing complementarity in a heteroduplex
US7838219B2 (en) 2001-02-02 2010-11-23 Novici Biotech Llc Method of increasing complementarity in a heteroduplex
US7273739B2 (en) 2002-02-01 2007-09-25 Padgett Hal S Nucleic acid molecules encoding endonucleases and methods of use thereof

Also Published As

Publication number Publication date
JPH06506355A (ja) 1994-07-21
JP3504658B2 (ja) 2004-03-08
EP0583265B1 (de) 1998-09-23
ATE171479T1 (de) 1998-10-15
EP0583265A1 (de) 1994-02-23
WO1992018645A1 (de) 1992-10-29
DE59209506D1 (de) 1998-10-29

Similar Documents

Publication Publication Date Title
EP0583265B1 (de) Verfahren zur herstellung von neuen biopolymeren
EP2175021B1 (de) Verfahren zur Herstellung von Polymeren
DE60126786T2 (de) Verfahren zur ortspezifischen massenmutagenese
DE69636721T2 (de) Screeningverfahren für enzyme und enzymkits
DE69734063T2 (de) Herstellung und verwendung von normalisierten dna-bibliotheken
DE69824004T2 (de) Verfahren zur quantitativen bestimmung der genexpression mit hilfe der multiplexen competitiven reversen-transkriptase polymerase kettenreaktion
DE69835360T2 (de) EVOLUTION Prokaryotischer GANZER ZELLEN DURCH REKURSIVE SEQUENZREKOMBINATION
DE69225333T2 (de) Verfahren für den Nachweis von Mikroorganismen unter verwendung von direkter undwillkürlicher DNA Amplifikation.
EP1181395A2 (de) Verfahren zur synthese von dna-fragmenten
DE69631787T2 (de) Verfahren zum screening enzymatischer aktivität
DE4343591A1 (de) Verfahren zum evolutiven Design und Synthese funktionaler Polymere auf der Basis von Formenelementen und Formencodes
WO2005030957A1 (de) Verfahren zur in vitro evolution von polypeptiden
EP2861339A1 (de) Analyseverfahren auf basis eines arrays
DE69737327T2 (de) Verfahren zur identifizierung von essentiellen genen für das wachstum eines organismus
DE60202196T2 (de) Orientationsgerichtete konstruktion von plasmiden
DE60115622T2 (de) Methoden und zusammensetzungen zur aufklärung von proteinexpressionsprofilen in zellen
DE60133556T2 (de) Verbesserte kombinatorische genbanken durch rekombination in hefe und analyseverfahren
DE10350474B4 (de) Verfahren zur Selektion von Biomolekülen aus Varianten-Bibliotheken von Biomolekülen
DE19957116A1 (de) Verfahren zur Herstellung synthetischer Nukleinsäuredoppelstränge
DE60034953T2 (de) Genklonierung
DE4237381C1 (de) Trägermaterial zur simultanen Bindung genotypischer und phänotypischer Substanzen
DE10232507C1 (de) Verfahren zum sequenzkontrollierten Herstellen eines Nukleinsäureprodukts
EP1266027A2 (de) Dynamische sequenzierung durch hybridisierung
DE60106749T2 (de) Verfahren zum screening von mikroorganismen unter nährstofflimitierten bedingungen
DE19957319A1 (de) Dynamische Bestimmung von Analyten

Legal Events

Date Code Title Description
8100 Publication of patent without earlier publication of application
D1 Grant (no unexamined application published) patent law 81
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: EVOTEC BIOSYSTEMS GMBH, 22529 HAMBURG, DE

8327 Change in the person/name/address of the patent owner

Owner name: EVOTEC BIOSYSTEMS AG, 22525 HAMBURG, DE

8327 Change in the person/name/address of the patent owner

Owner name: EVOTEC OAI AG, 22525 HAMBURG, DE

8327 Change in the person/name/address of the patent owner

Owner name: DIREVO BIOTECH, 50829 KOELN, DE

R071 Expiry of right